L. Pyhälä

1.3k total citations
26 papers, 1.1k citations indexed

About

L. Pyhälä is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Pyhälä has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Epidemiology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Pyhälä's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Response and Inflammation (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). L. Pyhälä is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Response and Inflammation (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). L. Pyhälä collaborates with scholars based in Finland, United States and Netherlands. L. Pyhälä's co-authors include Kari Cantell, K Cantell, Ilkka M. Helander, Anthony P. Moran, Anna Muotiala, T Kosunen, Aino Laurila, Kirsi Laitinen, M. Leinonen and Pekka Saikku and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

L. Pyhälä

26 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Pyhälä Finland 14 454 287 252 195 183 26 1.1k
M Schöller France 14 236 0.5× 204 0.7× 263 1.0× 72 0.4× 82 0.4× 29 821
Jean Gupta United States 13 772 1.7× 514 1.8× 212 0.8× 171 0.9× 56 0.3× 14 1.4k
J Mĕstecký United States 12 299 0.7× 96 0.3× 127 0.5× 88 0.5× 82 0.4× 20 830
Alun C. Kirby United Kingdom 19 662 1.5× 287 1.0× 243 1.0× 61 0.3× 72 0.4× 31 1.3k
J M Orenstein United States 15 359 0.8× 331 1.2× 193 0.8× 123 0.6× 133 0.7× 18 1.3k
Jesper Reinholdt Denmark 18 345 0.8× 306 1.1× 304 1.2× 46 0.2× 228 1.2× 33 1.5k
Keiko Fujihashi United States 18 884 1.9× 243 0.8× 168 0.7× 71 0.4× 99 0.5× 31 1.3k
David E. Justus United States 15 255 0.6× 206 0.7× 172 0.7× 59 0.3× 143 0.8× 30 789
K Madaliński Poland 19 346 0.8× 687 2.4× 187 0.7× 100 0.5× 27 0.1× 104 1.4k
S Montplaisir Canada 22 347 0.8× 428 1.5× 229 0.9× 68 0.3× 135 0.7× 78 1.2k

Countries citing papers authored by L. Pyhälä

Since Specialization
Citations

This map shows the geographic impact of L. Pyhälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pyhälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pyhälä more than expected).

Fields of papers citing papers by L. Pyhälä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pyhälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pyhälä. The network helps show where L. Pyhälä may publish in the future.

Co-authorship network of co-authors of L. Pyhälä

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pyhälä. A scholar is included among the top collaborators of L. Pyhälä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pyhälä. L. Pyhälä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moran, Anthony P., Jaana Vuopio‐Varkila, K Varkila, et al.. (1996). Biological characterization ofCampylobacter fetuslipopolysaccharides. FEMS Immunology & Medical Microbiology. 15(1). 43–50. 7 indexed citations
2.
Sareneva, Timo, Kari Cantell, L. Pyhälä, Jaana Pirhonen, & Ilkka Julkunen. (1993). Effect of Carbohydrates on the Pharmacokinetics of Human Interferon-γ. Journal of Interferon Research. 13(4). 267–269. 42 indexed citations
3.
Himanen, Juha P., et al.. (1993). Biological activities of lipoteichoic acid and peptidoglycan--teichoic acid of Bacillus subtilis 168 (Marburg). Journal of General Microbiology. 139(11). 2659–2665. 24 indexed citations
4.
Saarela, Maria, Sirkka Asikainen, Satu Alaluusua, et al.. (1992). Frequency and stability of mono‐or poly‐infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral Microbiology and Immunology. 7(5). 277–279. 160 indexed citations
5.
Muotiala, Anna, Ilkka M. Helander, L. Pyhälä, T Kosunen, & Anthony P. Moran. (1992). Low biological activity of Helicobacter pylori lipopolysaccharide. Infection and Immunity. 60(4). 1714–1716. 190 indexed citations
6.
Pyhälä, Riikka, et al.. (1988). Host cell-mediated selection of influenza A (H3N2) virus variant subpopulations: lack of association between antigenic and receptor-binding properties. Epidemiology and Infection. 100(3). 511–522. 3 indexed citations
7.
Vuopio‐Varkila, Jaana, Marjatta Nurminen, L. Pyhälä, & P. Helena Mäkelä. (1988). Lipopolysaccharide-induced non-specific resistance to systemic Escherichia coli infection in mice. Journal of Medical Microbiology. 25(3). 197–203. 23 indexed citations
8.
Pyhälä, Riikka, L. Pyhälä, M. Valle, & Kimmo Aho. (1987). Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology. Epidemiology and Infection. 99(3). 745–753. 16 indexed citations
9.
Pyhälä, L., et al.. (1987). Antigenic analysis of intraepidemic variants of influenza A (H3N2) viruses by hyperimmune rat antisera. Journal of Virological Methods. 15(4). 259–265. 3 indexed citations
10.
Cantell, K, Huub Schellekens, L. Pyhälä, et al.. (1986). Pharmacokinetic Studies with Human and Rat Interferons-γ in Different Species. Journal of Interferon Research. 6(6). 671–675. 13 indexed citations
11.
Pyhälä, Riikka, L. Pyhälä, & R. Visakorpi. (1986). Intraepidemic heterogeneity of influenza A (H3N2) viruses in 1985: antigenic analysis and sensitivity to non-specific inhibitors.. PubMed. 64(5). 277–84. 2 indexed citations
12.
Kerttula, Yrjö, Martti Vaara, L. Pyhälä, et al.. (1986). Effect of bacterial lipopolysaccharide on serum lipids and on the development of aortic atherosclerosis in rabbits. Atherosclerosis. 59(3). 307–312. 7 indexed citations
13.
Cantell, K, Walter Fiers, Sinikka Hirvonen, & L. Pyhälä. (1984). Circulating Interferon in Rabbits After Simultaneous Intramuscular Administration of Human Alpha and Gamma Interferons. Journal of Interferon Research. 4(2). 291–293. 9 indexed citations
14.
Pyhälä, L.. (1978). NEUTRALIZING ANTIBODIES AGAINST HUMAN LEUKOCYTE, LYMPHOBLASTOID AND FIBROBLAST INTERFERONS ELICITED BY IMMUNIZATION WITH HUMAN LEUKOCYTE INTERFERON. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 86C(1-6). 291–298. 3 indexed citations
15.
Pyhälä, L., et al.. (1978). TOXICITY STUDIES WITH HUMAN LEUKOCYTE INTERFERON IN NEWBORN RABBITS. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 86C(1-6). 45–51. 4 indexed citations
16.
Cantell, Kari & L. Pyhälä. (1976). Pharmacokinetics of Human Leukocyte Interferon. The Journal of Infectious Diseases. 133(Supplement 2). A6–A12. 34 indexed citations
17.
Mogensen, K. E., L. Pyhälä, & K Cantell. (1975). RAISING ANTIBODIES TO HUMAN LEUKOCYTE INTERFERON. Acta Pathologica Microbiologica Scandinavica Section B Microbiology. 83B(5). 443–450. 61 indexed citations
18.
Cantell, K, et al.. (1974). Human leukocyte interferon: production, purification, stability, and animal experiments.. PubMed. 35–8. 96 indexed citations
19.
Pyhälä, L. & Kari Cantell. (1974). Clearance of Human Interferon in Rabbits Induced to Make Rabbit Interferon. Experimental Biology and Medicine. 146(2). 394–397. 10 indexed citations
20.
Cantell, Kari & L. Pyhälä. (1973). Circulating Interferon in Rabbits after Administration of Human Interferon by Different Routes. Journal of General Virology. 20(1). 97–104. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Schöller Breakdown of academic impact, for papers by Jean Gupta Breakdown of academic impact, for papers by J Mĕstecký Breakdown of academic impact, for papers by Alun C. Kirby Breakdown of academic impact, for papers by J M Orenstein Breakdown of academic impact, for papers by Jesper Reinholdt Breakdown of academic impact, for papers by Keiko Fujihashi Breakdown of academic impact, for papers by David E. Justus Breakdown of academic impact, for papers by K Madaliński Breakdown of academic impact, for papers by S Montplaisir
Rankless by CCL
2026